Employers keep paying for the symptoms of obesity, diabetes, and metabolic syndrome while the root causes go untouched. We unpack why many wellness models fail, how insulin resistance hides for years, and what chronic disease reversal can look like when a physician-led metabolic health team measures the right signals and tapers meds safely. 
• metabolic syndrome as a dominant driver of employer healthcare costs 
• why low-fat guidance and ultra-processed food worsen hunger and outcomes 
• fasting insulin and CGMs as earlier and more actionable markers than glucose alone 
• nutritional ketosis versus diabetic ketoacidosis and why the terms get conflated 
• GLP-1 medication costs plus the idea of a structured GLP-1 off-ramp 
• reported outcomes including weight loss and guaranteed improvements in A1C and blood pressure 
• deprescribing as a safety requirement when health improves quickly 
• ROI logic for self-funded plans including claims reduction and lower pharmacy spend 
Call my cell phone, 262-255-9545. I’m Brett at Tord.health, not.com.